Akebia Therapeutics (AKBA) Reports Q4 Loss of $0.99

Akebia Therapeutics (NASDAQ: AKBA) reported Q4 EPS of ($0.99), versus ($0.66) reported last year.

For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Winnebago Industries (WGO) PT Lowered to $40 at Benchmark on Pressured NT Demand
• FirstCash to acquire UK pawn operator Ramsdens for £206 million